You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BUSPIRONE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Buspirone Hydrochloride patents expire, and what generic alternatives are available?

Buspirone Hydrochloride is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Amneal Pharms Co, Aurobindo Pharma Ltd, Egis, Epic Pharma Llc, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Oxford Pharms, Rising, Rubicon, Strides Pharma, Teva, Unichem, and Zydus Pharms. and is included in twenty-one NDAs.

The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Buspirone Hydrochloride

A generic version of BUSPIRONE HYDROCHLORIDE was approved as buspirone hydrochloride by IMPAX LABS INC on March 28th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BUSPIRONE HYDROCHLORIDE?
  • What are the global sales for BUSPIRONE HYDROCHLORIDE?
  • What is Average Wholesale Price for BUSPIRONE HYDROCHLORIDE?
Drug patent expirations by year for BUSPIRONE HYDROCHLORIDE
Recent Clinical Trials for BUSPIRONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 2
University of OxfordPhase 2
Valenta Pharm JSCPhase 3

See all BUSPIRONE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for BUSPIRONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for BUSPIRONE HYDROCHLORIDE

US Patents and Regulatory Information for BUSPIRONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075022-001 Feb 28, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075385-002 Mar 1, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 074253-001 Mar 28, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075467-004 Feb 28, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075413-002 Mar 19, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.